Characteristics of COVID-19 Pneumonia Survivors With Resting Normoxemia and Exercise-Induced Desaturation

References

1. 1.↵
   COVID-19 Dashboard by the Centre for Systems Science and Engineering (CSSE) at Johns Hopkins University. Available at: https://coronavirus.jhu.edu/map.html. Accessed February 5, 2021.
2. 2.↵
   1. Wu Z,
   2. McGoogan JM

   . Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239-1242.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Guan WJ,
   2. Ni ZY,
   3. Hu Y,
   4. Liang WH,
   5. Ou CQ,
   6. He JX,
   7. et al

   . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382(18):1708-1720.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Paneroni M,
   2. Simonelli C,
   3. Saleri M,
   4. Bertacchini L,
   5. Venturelli M,
   6. Troosters T,
   7. et al

   . Muscle strength and physical performance in patients without previous disabilities recovering from COVID-19 pneumonia. Am J Phys Med Rehabil 2021;100(2):105-109.

   OpenUrlPubMed
5. 5.↵
   1. Vitacca M,
   2. Migliori GB,
   3. Spanevello A,
   4. Melazzini MG,
   5. Ambrosino N,
   6. Ceriana P,
   7. et al

   . Management and outcomes of post-acute COVID-19 patients in northern Italy. Eur J Intern Med 2020;78:159-160.

   OpenUrl
6. 6.↵
   1. Vanhorebeek I,
   2. Latronico N,
   3. Van den Berghe G

   . Van den Berghe G. ICU-acquired weakness. Intensive Care Med 2020;46(4):637-653.

   OpenUrlCrossRef
7. 7.↵
   1. Paneroni M,
   2. Vogiatzis I,
   3. Bertacchini L,
   4. Simonelli C,
   5. Vitacca M

   . Predictors of low physical function in patients with COVID-19 with acute respiratory failure admitted to a sub-acute unit. Arch Phys Med Rehab 2021;102(6):1228-1231.

   OpenUrl
8. 8.↵
   1. Waschki B,
   2. Kirsten AM,
   3. Holz O,
   4. Mueller K-C,
   5. Schaper M,
   6. Sack A-L,
   7. et al

   . Disease progression and changes in physical activity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015;192(3):295-306.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Richeldi L,
   2. Collard HR,
   3. Jones MG

   . Idiopathic pulmonary fibrosis. Lancet 2017;389(10082):1941-1952.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Khor YH,
    2. Renzoni EA,
    3. Visca D,
    4. McDonald CF,
    5. Goh NSL

    . Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns. ERJ Open Res 2019;5(3):00118-2019.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Stolz D,
    2. Boersma W,
    3. Blasi F,
    4. Louis R,
    5. Milenkovic B,
    6. Kostikas K,
    7. et al

    . Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin. Chest 2014;146(2):328-338.

    OpenUrl
12. 12.↵
    1. Vainshelboim B,
    2. Kramer MR,
    3. Izhakian S,
    4. Lima RM,
    5. Oliveira J

    . Physical activity and exertional desaturation are associated with mortality in idiopathic pulmonary fibrosis. J Clin Med 2016;5(8):73.

    OpenUrl
13. 13.↵
    1. Ceriana P,
    2. Nava S,
    3. Vitacca M,
    4. Carlucci A,
    5. Paneroni M,
    6. Schreiber A,
    7. et al

    . Noninvasive ventilation during weaning from prolonged mechanical ventilation. Pulmonology 2019;25(6):328-333.

    OpenUrl
14. 14.↵
    1. Maestri R,
    2. Bruschi C,
    3. Fracchia C,
    4. Pinna GD,
    5. Fanfulla F,
    6. Ambrosino N

    . Physiological and clinical characteristics of patients with COPD admitted to an inpatient pulmonary rehabilitation program: a real-life study. Pulmonology 2019;25(2):71-78.

    OpenUrl
15. 15.↵
    1. Ippolito M,
    2. Vitale F,
    3. Accurso G,
    4. Iozzo P,
    5. Gregoretti C,
    6. Giarratano A,
    7. Cortegiani A

    . Medical masks and respirators for the protection of healthcare workers from SARS-CoV-2 and other viruses. Pulmonology 2020;26(4):204-212.

    OpenUrl
16. 16.
    1. Winck JC,
    2. Ambrosino N

    . COVID-19 pandemic and non invasive respiratory management: every Goliath needs a David. An evidence based evaluation of problems. Pulmonology 2020;26(4):213-220.

    OpenUrl
17. 17.
    1. Vitacca M,
    2. Carone M,
    3. Clini EM,
    4. Paneroni M,
    5. Lazzeri M,
    6. Lanza A,
    7. et al

    . Joint statement on the role of respiratory rehabilitation in the COVID-19 crisis: the Italian Position Paper. Respiration 2020;99(6):493-499.

    OpenUrlPubMed
18. 18.↵
    NIH. COVID-19 Treatment Guidelines. Last update February 11, 2021. Available at: https://www.COVID19treatmentguidelines.nih.gov/therapeutic-options-under-investigation. Accessed February 22, 2021.
19. 19.↵
    Global strategy for prevention, diagnosis and management of COPD. Report 2020. Available at: http://goldcopd.org/gold-reports/. Accessed February 22, 2021.
20. 20.↵
    1. Raghu G,
    2. Rochwerg B,
    3. Zhang Y,
    4. Garcia CA,
    5. Azuma A,
    6. Behr J,
    7. et al

    . An official ATS/ERS/JRS/ALAT Clinical Practice Guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med 2015;192(2):e3-e19.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Ryerson CJ,
    2. Vittinghoff E,
    3. Ley B,
    4. Lee JS,
    5. Mooney JJ,
    6. Jones KD,
    7. et al

    . Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest 2014;145(4):723-728.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al

    . Standardisation of spirometry. Eur Respir J 2005;26(2):319-338.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Quanjer PH

    . Working party on “Standardization of lung function test. Bull. Eur. Physiopathol Respir 1983;19(Suppl 5):7-10.

    OpenUrlPubMedWeb of Science
24. 24.↵
    1. Thompson BR,
    2. Johns DP,
    3. Bailey M,
    4. Raven J,
    5. Walters EH,
    6. Abramson MJ

    . Prediction equations for single breath diffusing capacity (Tlco) in a middle aged Caucasian population. Thorax 2008;63(10):889-893.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Holland AE,
    2. Spruit MA,
    3. Troosters T,
    4. Puhan MA,
    5. Pepin V,
    6. Saey D,
    7. et al

    . An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014;44(6):1428-1446.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Enright PL,
    2. Sherrill DL

    . Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998;158(5 Pt 1):1384-1387.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Borg G

    . Psychophysical basis of perceived exertion. Med Sci Sports Exerc 1982;14(5):377-381.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Poulain M,
    2. Durand F,
    3. Palomba B,
    4. Ceugniet F,
    5. Desplan J,
    6. Varray A,
    7. Préfaut C

    . 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest 2003;123(5):1401-1407.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Fletcher CM

    . Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). Br Med J 1960;2:1665.

    OpenUrlFREE Full Text
30. 30.↵
    1. Morin L,
    2. Savale L,
    3. Pham T,
    4. Colle R,
    5. Figueiredo S,
    6. et al

    Writing Committee for the COMEBAC Study Group; Morin L, Savale L, Pham T, Colle R, Figueiredo S, et al. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA 2021;325(15):1525-1534.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Huang C,
    2. Huang L,
    3. Wang Y,
    4. Li X,
    5. Ren L,
    6. Gu X,
    7. et al

    . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397(10270):220-232.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Shah AS,
    2. Wong AW,
    3. Hague CJ,
    4. Murphy DT,
    5. Johnston JC,
    6. Ryerson CJ,
    7. Carlsten C

    . A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2021;76(4):402-404.

    OpenUrlAbstract/FREE Full Text
33. 33.↵
    1. Torres-Castro R,
    2. Vasconcello-Castillo L,
    3. Alsina-Restoy X,
    4. Solis-Navarro L,
    5. Burgos F,
    6. Puppo H,
    7. Vilaró J

    . Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology 2020;27(4):328-337.

    OpenUrl
34. 34.↵
    1. Oldani S,
    2. Ravaglia C,
    3. Bensai S,
    4. Bertolovic L,
    5. Ghirotti C,
    6. Puglisi S,
    7. et al

    . Pathophysiology of light phenotype SARS-CoV-2 interstitial pneumonia: from histopathological features to clinical presentations. Pulmonology 2021:2531-0437(21)0078-7. https://doi.org/10.1016/j.pulmoe.2021.03.003 [Epub ahead of print].
35. 35.
    1. Doglioni C,
    2. Ravaglia C,
    3. Chilosi M,
    4. Rossi G,
    5. Dubini A,
    6. Pedica F,
    7. et al

    . Covid-19 interstitial pneumonia: histological and immunohistochemical features on cryobiopsies. Respiration 2021;100(6):488-498.

    OpenUrl
36. 36.↵
    1. Piciucchi S,
    2. Ravaglia C,
    3. Vizzuso A,
    4. Bertocco M,
    5. Poletti V

    . Reversibility of venous dilatation and parenchymal changes density in Sars-Cov-2 pneumonia: toward the definition of a peculiar pattern. Pulmonology 2020;27(4):353-357.

    OpenUrl
37. 37.↵
    1. Shmueli H,
    2. Shah M,
    3. Ebinger JE,
    4. Nguyen LC,
    5. Chernomordik F,
    6. Flint N,
    7. et al

    . Left ventricular global longitudinal strain in identifying subclinical myocardial dysfunction among patients hospitalized with COVID-19. Int J Cardiol Heart Vasc 2021;32:100719.

    OpenUrl
38. 38.↵
    1. Andrianopoulos V,
    2. Franssen FME,
    3. Peeters JPI,
    4. Ubachs TJA,
    5. Bukari H,
    6. Groenen M,
    7. et al

    . Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia. Respir Physiol Neurobiol 2014;190:40-46.

    OpenUrlCrossRefPubMed
39. 39.↵
    1. Du Plessis JP,
    2. Fernandes S,
    3. Jamal R,
    4. Camp P,
    5. Johannson K,
    6. Schaeffer M,
    7. et al

    . Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD. Respirology 2018;23(4):392-398.

    OpenUrl
40. 40.↵
    1. Lama VN,
    2. Flaherty KR,
    3. Toews GB,
    4. Colby TV,
    5. Travis WD,
    6. Long Q,
    7. et al

    . Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003;168(9):1084-1090.

    OpenUrlCrossRefPubMedWeb of Science
41. 41.↵
    1. Lettieri CJ,
    2. Nathan SD,
    3. Browning RF,
    4. Barnett SD,
    5. Ahmad S,
    6. Shorr AF

    . The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med 2006;100(10):1734-1741.

    OpenUrlCrossRefPubMedWeb of Science
42. 42.↵
    1. Donner CF,
    2. Ambrosino N,
    3. Goldstein RS (eds)

    1. Palange P,
    2. Casaburi R

    . Supplemental oxygen and heliox. Donner CF, Ambrosino N, Goldstein RS (eds). Pulmonary Rehabilitation. 2nd Edition, Boca Raton, FL: USA CRC Press Pub, 441-445, 2020
43. 43.↵
    1. Donner CF,
    2. Ambrosino N,
    3. Goldstein RS

    1. Ambrosino N

    . Interstitial lung diseases. Donner CF, Ambrosino N, Goldstein RS, (eds). Pulmonary Rehabilitation. 2nd Edition Boca Raton FL, USA: CRC Press Pub. Pp 373-378. 2020.